All times are listed in CEST (Central European Summer Time)

Displaying One Session

View
Educational session

First-line therapy in advanced melanoma: What is my preferred choice?

Date
Fri, 20.10.2023
Time
14:00 - 15:30
Chairs
  • Teresa Petrella (Toronto, Canada)
  • Reinhard Dummer (Zurich, Switzerland)
Room
Salamanca Auditorium - Hall 3
Session Type
Educational session
Educational session

My preferred choice is PD-1 monotherapy, and these are the reasons why

Speakers
  • Teresa Petrella (Toronto, Canada)
Lecture Time
14:00 - 14:25
Session Name
First-line therapy in advanced melanoma: What is my preferred choice? (ID 6)
Room
Salamanca Auditorium - Hall 3
Date
Fri, 20.10.2023
Time
14:00 - 15:30
Educational session

My preferred choice is combined immunotherapy with PD1+CTLA-4, and these are the reasons why

Speakers
  • Ana Maria Arance Fernandez (Barcelona, Spain)
Lecture Time
14:25 - 14:50
Session Name
First-line therapy in advanced melanoma: What is my preferred choice? (ID 6)
Room
Salamanca Auditorium - Hall 3
Date
Fri, 20.10.2023
Time
14:00 - 15:30
Educational session

I prefer the combination of anti-PD-1 and anti-LAG-3, and these are the reasons why

Speakers
  • Reinhard Dummer (Zurich, Switzerland)
Lecture Time
14:50 - 15:15
Session Name
First-line therapy in advanced melanoma: What is my preferred choice? (ID 6)
Room
Salamanca Auditorium - Hall 3
Date
Fri, 20.10.2023
Time
14:00 - 15:30
Educational session

Q&A and Discussion

Speakers
  • All Speakers (Lugano, Switzerland)
Lecture Time
15:15 - 15:30
Session Name
First-line therapy in advanced melanoma: What is my preferred choice? (ID 6)
Room
Salamanca Auditorium - Hall 3
Date
Fri, 20.10.2023
Time
14:00 - 15:30